Literature DB >> 1497620

Human placental beta-galactosidase. Characterization of the dimer and complex forms of the enzyme.

M Hubbes1, R M D'Agrosa, J W Callahan.   

Abstract

GM1 ganglioside beta-galactosidase (beta-Gal) is deficient in the autosomal recessive disorder GM1 gangliosidosis. A portion of the enzyme occurs in a complex with neuraminidase and an additional glycoprotein, protective protein, but the nature of the interactions conferring the stability of the complex is unknown. Affinity chromatography of beta-Gal on p-aminophenylthiogalactose-Sepharose (PATG-Sepharose) at pH 4.3, the pH optimum of beta-Gal, resulted in a 260-fold enrichment of beta-Gal, but the major protein in the fraction had an M(r) value of 74,000. Affinity chromatography on PATG-Sepharose at pH 5.2 showed substantial enrichment (4000-fold) of beta-Gal, and the mature form of the enzyme (M(r) 64,000) was the major protein in the preparation. Using h.p.l.c. molecular-sieve chromatography, we found that about 15% of the total beta-Gal occurred in a high-M(r) form (greater than 600,000), the presumptive complex, with 85% eluting at M(r) 150,000, suggestive of a dimer. This distribution was independent of both high (60 mg/ml) and low (5 mg/ml) protein concentration and the pH (pH 4.3 or 5.2) of the sample applied to the column. Furthermore, incubation for 90 min at 37 degrees C, conditions which had previously been suggested as optimal for formation of the complex, had no effect on this distribution. Further fractionation by anion-exchange chromatography and a second affinity column step yielded a beta-Gal preparation that contained a single polypeptide chain (M(r) 64,000), was devoid of neuraminidase and protective protein (absent carboxypeptidase activity), and when injected into rabbits gave rise to monospecific rabbit antisera. We conclude that the protein composition of the complex is variable (i.e. it is different when isolated at pH 4.3 and 5.2) and that the amount of beta-Gal tightly associated with the complex constitutes a small fraction of the total beta-Gal activity. The more prevalent form of the enzyme is a beta-Gal homodimer that is stable and devoid of either neuraminidase activity or protective protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497620      PMCID: PMC1132870          DOI: 10.1042/bj2850827

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Involvement of thiol proteases in galactosialidosis.

Authors:  E Takeda; Y Kuroda; K Toshima; E Naito; M Ito; M Miyao; E Kominami; N Katunuma
Journal:  Clin Chim Acta       Date:  1986-03-16       Impact factor: 3.786

2.  Characterization of the acid beta-D-galactosidases from human urine.

Authors:  B C Kress; A L Miller
Journal:  Clin Chim Acta       Date:  1978-04-03       Impact factor: 3.786

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Separation and isolation of rat and human intestinal beta-galactosidases.

Authors:  D H Alpers
Journal:  J Biol Chem       Date:  1969-03-10       Impact factor: 5.157

5.  GM1 ganglioside beta-galactosidase. A. Purification and studies of the enzyme from human liver.

Authors:  A G Norden; L L Tennant; J S O'Brien
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

6.  Enzymatic hydrolysis of sphingolipids. V. Hydrolysis of monosialoganglioside and hexosylceramides by rat brain beta-galactosidase.

Authors:  S Gatt
Journal:  Biochim Biophys Acta       Date:  1967-02-14

7.  The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver.

Authors:  P S Cheetham; N E Dance
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

8.  Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases.

Authors:  N J Galjart; N Gillemans; A Harris; G T van der Horst; F W Verheijen; H Galjaard; A d'Azzo
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

9.  Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.

Authors:  F W Verheijen; S Palmeri; A T Hoogeveen; H Galjaard
Journal:  Eur J Biochem       Date:  1985-06-03

10.  In vitro activation of neuraminidase in the beta-galactosidase-neuraminidase-protective protein complex by cathepsin C.

Authors:  R M D'Agrosa; J W Callahan
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

View more
  8 in total

1.  Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.

Authors:  S Zhang; R Bagshaw; W Hilson; Y Oho; A Hinek; J T Clarke; J W Callahan
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.

Authors:  Umeharu Ohto; Kimihito Usui; Toshinari Ochi; Kenjiro Yuki; Yoshinori Satow; Toshiyuki Shimizu
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

3.  Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.

Authors:  Brigitte A Rigat; Michael B Tropak; Justin Buttner; Ellen Crushell; Daphne Benedict; John W Callahan; Douglas R Martin; Don J Mahuran
Journal:  Mol Genet Metab       Date:  2012-06-19       Impact factor: 4.797

4.  Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity.

Authors:  Chi-Fan Yang; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-09-30       Impact factor: 8.410

5.  Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells.

Authors:  S Zhang; J D McCarter; Y Okamura-Oho; F Yaghi; A Hinek; S G Withers; J W Callahan
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase.

Authors:  A Hinek; M Rabinovitch; F Keeley; Y Okamura-Oho; J Callahan
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts.

Authors:  R M D'Agrosa; M Hubbes; S Zhang; R Shankaran; J W Callahan
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

8.  Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.

Authors:  Y Okamura-Oho; S Zhang; W Hilson; A Hinek; J W Callahan
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.